Physician profile
Eric Tyler Czer
NPI 1023464989
$1,109.26
in general payments reported to CMS, 2019-2025
12 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $71.42 · 2023: $250 · 2024: $305 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $302.25 | 2021-2024 | Xiaflex |
| Axogen | $160.12 | 2022-2025 | Axoguard Ha+ Nerve Protector, Avance Nerve Graft, Axoguard Nerve Connector |
| Smith+Nephew, INC. | $135.89 | 2021-2024 | Grafix Pl, Renasys Go V2 Home, Pico 7 |
| Bioventus LLC | $121.85 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Endo USA, INC. | $93.25 | 2024-2025 | Xiaflex |
| Stryker Corporation | $86.42 | 2023-2025 | Hoffmann, Na, Allograft Bio-Implants |
| Medartis INC. | $74.67 | 2024 | Aptus |
| Integra Lifesciences Corporation | $38.45 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Ebi, LLC | $30.47 | 2025 | Biomet Ebi Bone Healing System |
| Merz Pharmaceuticals, LLC | $27.32 | 2025 | Xeomin |
| Acera Surgical, INC. | $23.36 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $15.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Czer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.